Patient#	Sample#	IL27/IL27R/JAK2/TYK2:(IL27/EBI3, active),(IL27R/JAK2/TYK2, active),	MAPKKK cascade:(IL27/IL27R/JAK2/TYK2, active),	STAT1-3 (dimer):(IL27/IL27R/JAK2/TYK2, active),	T cell proliferation during immune response:(IL27/IL27R/JAK2/TYK2, active),	T-helper 2 cell differentiation:(IL27/IL27R/JAK2/TYK2, active),	cytokine production during immune response:(IL27/IL27R/JAK2/TYK2, active),	mast cell activation:(IL27/IL27R/JAK2/TYK2, active),	positive regulation of T cell mediated cytotoxicity:(IL27/IL27R/JAK2/TYK2, active),	IL6:(IL6, protein),	JAK1:(JAK1, protein),	STAT2:(STAT2, protein),	STAT3:(STAT3, protein),	STAT4:(STAT4, protein),	STAT5A:(STAT5A, protein),	TGFB1:(TGFB1, protein),	gp130:(gp130, protein),	IFNG:(IFNG, protein),	IL2:(IL2, protein),	STAT1:(STAT1, protein),	STAT2 (dimer):(IL27/IL27R/JAK2/TYK2, active),(STAT2, active),	STAT4 (dimer):(IL27/IL27R/JAK2/TYK2, active),(STAT4, active),	STAT5A (dimer):(IL27/IL27R/JAK2/TYK2, active),(STAT5A, active),	T cell proliferation:(CD4-positive alpha-beta T cell lineage commitment, active),(IL27/IL27R/JAK2/TYK2, active),(IL6, active),	IL12A:(IL12A, protein),	IL18:(IL18, protein),	IL1B:(IL1B, protein),	STAT3 (dimer):(IL27/IL27R/JAK2/TYK2, active),(STAT3, active),	TNF:(TNF, protein),	positive regulation of mast cell cytokine production:(STAT3 (dimer), active),	IL27RA:(IL27RA, protein),	IL27RA/JAK1:(IL27RA, active),(JAK1, active),	IL27/IL27R/JAK1:(IL27/EBI3, active),(IL27RA/JAK1, active),(gp130, active),	STAT1 (dimer):(IL27/IL27R/JAK1, active),(IL27/IL27R/JAK2/TYK2, active),(STAT1, active),	GATA3:(GATA3, protein),	IL12RB2:(IL12RB2, protein),	IL17A:(IL17A, protein),	TBX21:(TBX21, protein),	T-helper cell lineage commitment:(IL17A, active),	
